Cargando…

Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases

INTRODUCTION AND OBJECTIVES: Lower antibody (Ab) responses after SARS-CoV-2 vaccination have been reported in liver transplant (LT) recipients and those with chronic liver diseases (CLD). The role of a booster dose in those with poor responses to initial vaccination is not well defined. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chauhan, Mahak, Nzeako, Ihechiluru, Li, Feng, Thuluvath, Paul J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942457/ https://www.ncbi.nlm.nih.gov/pubmed/35338012 http://dx.doi.org/10.1016/j.aohep.2022.100702

Ejemplares similares

94: ANTIBODY RESPONSE AFTER A BOOSTER DOSE OF SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS AND THOSE WITH CHRONIC LIVER DISEASES
por: Chauhan, Mahak, et al.
Publicado: (2022)

Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases
por: Thuluvath, Paul J., et al.
Publicado: (2021)

Sustainability of humoral immunity induced by the SARS-CoV-2 vaccine and response to booster dose among Liver Transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2022)

Anti-SARS-CoV-2 vaccine in liver transplantation
por: Kotsiliti, Eleni
Publicado: (2022)

Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients
por: Toniutto, Pierluigi, et al.
Publicado: (2023)

Hyperhomocysteinaemia in liver transplant recipients
por: Nkansa-Dwamema, David, et al.
Publicado: (2004)

Antibody response to 2- and 3-dose SARS-CoV-2 mRNA vaccination in pediatric and adolescent kidney transplant recipients
por: Crane, Clarkson, et al.
Publicado: (2022)

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
por: Karaba, Andrew H., et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients
por: Strauss, Alexandra T., et al.
Publicado: (2022)

SARS-COV-2 antibodies after booster vaccination. Identification of subgroups with poor response
por: Ayuso García, B., et al.
Publicado: (2023)

Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in liver transplant recipients
por: Herrán, Aitor Odriozola, et al.
Publicado: (2022)

Analysis of Antibody Responses After COVID-19 Vaccination in Liver Transplant Recipients: A Single-Center Study
por: Oh, Young Ju, et al.
Publicado: (2023)

Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients
por: Kawabe, Mayuko, et al.
Publicado: (2023)

Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients
por: Easdale, Sandra, et al.
Publicado: (2021)

Humoral response to heterologous prime‐booster vaccination in heart transplant recipients aged 18–70 years primed with a viral vector SARS‐CoV‐2 vaccine
por: Tanner, Richard, et al.
Publicado: (2022)

Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5–adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients
por: Fernández-Ruiz, Mario, et al.
Publicado: (2023)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

Predictive factors of antibody response after anti-SARS-CoV-2 vaccine in liver transplant recipients
por: Kounis, Ilias, et al.
Publicado: (2022)

Determinants of Antibody Response to SARS-CoV-2 Vaccines in Liver Transplant Recipients: The Role of Immunosuppression Reduction
por: Cheng, Chih-Hsien, et al.
Publicado: (2022)

Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients
por: Hoffman, T.W., et al.
Publicado: (2022)

Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2022)

Mycophenolate mofetil decreases humoral responses to three doses of SARS‐CoV‐2 vaccine in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

Third dose of SARS-COV2 mRNA-vaccine in liver transplant recipients: can it bridge the response gap?
por: Montalbano, Marzia, et al.
Publicado: (2022)

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2021)

Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?
por: Stellini, Roberto, et al.
Publicado: (2022)

Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
por: Chavarot, Nathalie, et al.
Publicado: (2021)

Strong SARS-CoV-2 Antibody Response After Booster Dose of BNT162b2 mRNA Vaccines in Uninfected Healthcare Workers
por: Kwon, Seok Ryun, et al.
Publicado: (2022)

Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant
por: Del Mastro, Andrea, et al.
Publicado: (2023)

Partial recovery of SARS-CoV-2 immunity after booster vaccination in renal transplant recipients
por: Urra, J.M., et al.
Publicado: (2023)

Letter to the editor: Six‐month antibody kinetics and durability in liver transplant recipients after two doses of SARS‐CoV‐2 mRNA vaccination
por: Chang, Amy, et al.
Publicado: (2022)

Durability of Immune Response after Application of a Third Dose of SARS-CoV-2 Vaccination in Liver Transplant Recipients
por: Passenberg, Moritz, et al.
Publicado: (2023)

Determinants of Antibody Response to a Third SARS-CoV-2 mRNA Vaccine Dose in Solid Organ Transplant Recipients: Results from the Prospective Cohort Study COVAC-Tx
por: Balsby, Daniel, et al.
Publicado: (2022)

SARS-CoV-2 vaccine alleviates disease burden and severity in liver transplant recipients even with low antibody titers
por: Khalaileh, Abed, et al.
Publicado: (2023)

Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient
por: Dumortier, Jérôme
Publicado: (2022)

Humoral Immune Response following SARS-CoV-2 Vaccination in Liver Transplant Recipients
por: Timmermann, Lea, et al.
Publicado: (2021)

Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients
por: Toapanta-Yanchapaxi, Liz, et al.
Publicado: (2022)

Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients
por: Jadaun, Shekhar Singh, et al.
Publicado: (2022)

Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study
por: Wang, Pusen, et al.
Publicado: (2016)

COVID-19 in Liver Transplant Recipients: An Initial Experience From the US Epicenter
por: Lee, Brian T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ds6mfqo0bitg86969ivl9do31n